NASDAQ$SBRA

Sabra Health Care REIT Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Sabra's portfolio continued to grow stronger with improvements in coverage, occupancy, and NOI. The balance sheet remained strong and poised to support future growth.

Sabra Health Care REIT reported first quarter 2024 results, with net income of $0.11 per diluted common share, FFO of $0.32, Normalized FFO of $0.34, AFFO of $0.35, and Normalized AFFO of $0.35. The company reiterated its 2024 earnings guidance. Sabra's portfolio continues to grow stronger, with improvements in coverage, occupancy, and NOI.

  • Net Income: $0.11 per diluted common share
  • FFO: $0.32 per share
  • Normalized FFO: $0.34 per share
  • AFFO: $0.35 per share

Headline financials

Total Revenue

$167M

Previous: $161M+3.4%
EPS

$0.11

Previous: $0.34-67.6%
FFO per diluted common share

$0.32

Previous: $0.32+0.0%
Normalized FFO per share

$0.34

Previous: $0.33+3.0%
AFFO per diluted common share

$0.35

Previous: $0.33+6.1%
Normalized AFFO per share

$0.35

Previous: $0.34+2.9%
Capital Expenditures

-$12.9M

Previous: -$59.2M+78.1%
Free Cash Flow

$13.3M

Previous: -$68.7M+119.4%
Net Income

$26.3M

Previous: -$9.49M+376.7%
Operating Income

$152M

Previous: $144M+5.7%
Gross Profit

$167M

Previous: $161M+3.3%
Cash & Equivalents

$59.9M

Previous: $33.5M+78.7%
Total Assets

$5.37B

Previous: $5.56B-3.3%
Stock-Based Comp

$2.52M

Previous: $2.23M+13.1%

Revenue & EPS history

Sabra Health Care REIT · Revenue · Quarterly

$167M

Q1 2024+3.4%vs Q1 2023
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Sabra Health Care REIT · $162M total across 3 segments · Q3 2023

  • Rental and related revenues
    $93.1M+10.5%
  • Resident fees and services
    $59.7M+25.5%
  • Interest and other income
    $8.79M-1.6%

Forward guidance

Sabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share): •Net Income: $0.53 - $0.57 •FFO: $1.33 - $1.37 •Normalized FFO: $1.34 - $1.38 •AFFO: $1.38 - $1.42 •Normalized AFFO: $1.39 - $1.43 Earnings guidance above assumes no 2024 acquisition or disposition activity.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-0.5%

Avg return

Earnings day

-0.2%

Avg return

5 days after

-0.4%

Avg return

30 days after

45%

27 / 60 earnings

Positive

+10.4%

Q1 2022

Best reaction

-13.1%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.5%+0.1%-2.3%
Q3 2025+2.3%+4.2%+11.7%
Q1 2025+1.2%+0.1%-0.2%
Q4 2024-1.0%-0.8%+4.3%
Q3 2024-4.8%-4.1%-4.3%
Q2 2024-0.1%-1.1%+4.7%
Q1 2024-1.7%-1.7%-5.1%
Q4 2023+0.4%+0.4%+6.0%
Q3 2023+0.7%+2.0%+1.6%
Q2 2023+0.8%-0.9%-1.2%
Q1 2023-0.5%+1.7%+1.7%
Q4 2022-4.2%-6.3%-22.0%
Q3 2022-13.1%-3.5%-7.1%
Q2 2022+0.0%+2.9%-4.0%
Q1 2022+10.4%+6.0%+10.4%
Q4 2021-3.9%-0.7%+5.6%
Q3 2021-2.1%-0.1%-11.2%
Q2 2021-3.7%-4.7%-8.7%
Q1 2021-2.2%+0.0%-1.3%
Q4 2020+1.7%-3.6%-0.8%
Q3 2020-4.0%+15.7%+27.6%
Q2 2020+4.4%+7.7%+5.9%
Q1 2020-5.7%-1.6%+35.6%
Q4 2019-3.5%-11.1%-50.1%
Q3 2019+3.3%+0.6%-6.4%
Q2 2019+5.5%+4.5%+8.5%
Q1 2019-1.6%+0.5%-0.5%
Q4 2018-2.7%-9.6%-2.0%
Q3 2018-0.6%-1.4%-12.9%
Q2 2018-0.3%-0.3%+3.4%
Q1 2018+3.3%+2.9%+7.6%
Q4 2017+2.8%+4.8%+0.2%
Q3 2017-1.5%-2.7%-2.7%
Q2 2017+1.6%+0.9%-4.1%
Q1 2017-10.2%-8.8%-14.2%
Q4 2016+0.6%+5.4%+6.7%
Q3 2016-8.9%-7.2%-0.4%
Q2 2016+1.6%+2.4%+6.6%
Q1 2016+4.4%
Q4 2015+8.3%
Q3 2015-2.9%
Q2 2015-4.6%
Q1 2015-6.0%
Q4 2014-0.9%
Q3 2014-0.9%
Q2 2014-2.0%
Q1 2014-2.6%
Q4 2013+0.8%
Q3 2013+4.1%
Q2 2013-7.3%
Q1 2013+2.4%
Q4 2012+0.0%
Q3 2012+2.6%
Q2 2012+3.0%
Q1 2011-4.6%
Q1 2012+2.4%
Q4 2011+5.1%
Q3 2011+7.5%
Q2 2011+3.9%
Q4 2010-6.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro